{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:17:40Z","timestamp":1791821860277,"version":"4.3.4"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"\n Importance<\/jats:title>\n Opioid misuse and opioid use disorder (OUD) are important comorbidities in people with advanced cancer and cancer-related pain, but there is a lack of consensus on treatment.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop consensus among palliative care and addiction specialists on the appropriateness of various opioid management strategies in individuals with advanced cancer-related pain and opioid misuse or OUD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n For this qualitative study, using ExpertLens, an online platform and methodology for conducting modified Delphi panels, between August and October 2020, we conducted 2 modified Delphi panels to understand the perspectives of palliative and addiction clinicians on 3 common clinical scenarios varying by prognosis (weeks to months vs months to years). Of the 129 invited palliative or addiction medicine specialists, 120 participated in at least 1 round. A total of 84 participated in all 3 rounds.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Consensus was investigated for 3 clinical scenarios: (1) a patient with a history of an untreated opioid use disorder, (2) a patient taking more opioid than prescribed, and (3) a patient using nonprescribed benzodiazepines.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Participants were mostly women (47 [62%]), White (94 (78 [65%]), and held MD\/DO degrees (115 [96%]). For a patient with untreated OUD, regardless of prognosis, it was deemed appropriate to begin treatment with buprenorphine\/naloxone and inappropriate to refer to a methadone clinic. Beginning split-dose methadone was deemed appropriate for patients with shorter prognoses and of uncertain appropriateness for those with longer prognoses. Beginning a full opioid agonist was deemed of uncertain appropriateness for those with a short prognosis and inappropriate for those with a longer prognosis. Regardless of prognosis, for a patient with no medical history of OUD taking more opioids than prescribed, it was deemed appropriate to increase monitoring, inappropriate to taper opioids, and of uncertain appropriateness to increase the patient\u2019s opioids or transition to buprenorphine\/naloxone. For a patient with a urine drug test positive for non-prescribed benzodiazepines, regardless of prognosis, it was deemed appropriate to increase monitoring, inappropriate to taper opioids and prescribe buprenorphine\/naloxone.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The findings of this qualitative study provide urgently needed consensus-based guidance for clinicians and highlight critical research and policy gaps.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2022.2191","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T11:32:48Z","timestamp":1656588768000},"page":"1107","source":"Crossref","is-referenced-by-count":55,"title":["Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder"],"prefix":"10.1001","volume":"8","author":[{"given":"Katie","family":"Fitzgerald Jones","sequence":"first","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts"},{"name":"VA Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Khodyakov","sequence":"additional","affiliation":[{"name":"RAND Corporation, Santa Monica, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Arnold","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Bulls","sequence":"additional","affiliation":[{"name":"CHAllenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Dao","sequence":"additional","affiliation":[{"name":"RAND Corporation, Santa Monica, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kapo","sequence":"additional","affiliation":[{"name":"MSCE Palliative Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Palliative Medicine, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Paice","sequence":"additional","affiliation":[{"name":"RN Feinberg School of Medicine, Division of Hematology-Oncology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Liebschutz","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Merlin","sequence":"additional","affiliation":[{"name":"CHAllenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"coi220025r1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives.","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"coi220025r2","first-page":"386","article-title":"Navigating cancer pain management in the midst of the opioid epidemic.","volume":"32","author":"Paice","year":"2018","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"coi220025r3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3322\/caac.v61:3","article-title":"The management of cancer pain.","volume":"61","author":"Paice","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"coi220025r4","doi-asserted-by":"publisher","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder.","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"coi220025r5","doi-asserted-by":"publisher","first-page":"e2013605","DOI":"10.1001\/jamanetworkopen.2020.13605","article-title":"National patterns in prescription opioid use and misuse among cancer survivors in the United States.","volume":"3","author":"Jairam","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"coi220025r6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis.","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"coi220025r7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpainsymman.2020.08.015","article-title":"Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review.","volume":"61","author":"Jones","year":"2021","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"coi220025r8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1200\/JOP.2017.026120","article-title":"Under pressure: the tension between access and abuse of opioids in cancer pain management.","volume":"13","author":"Paice","year":"2017","journal-title":"J Oncol Pract"},{"issue":"3","key":"coi220025r9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.radonc.2011.09.016","article-title":"Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy.","volume":"101","author":"Zenda","year":"2011","journal-title":"Radiotherapy and Oncology"},{"key":"coi220025r10","first-page":"S7","article-title":"NCCN oncology risk evaluation and mitigation strategies white paper: recommendations for stakeholders: a review.","volume":"8","author":"Johnson","year":"2010","journal-title":"JNCCN"},{"issue":"4","key":"coi220025r13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11670-011-0317-7","article-title":"Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.","volume":"23","author":"Zhu","year":"2011","journal-title":"Chin J Cancer Res"},{"issue":"10","key":"coi220025r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study.","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"13","key":"coi220025r15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths.","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"coi220025r16","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"218","key":"coi220025r17","first-page":"1","article-title":"The effectiveness and risks of long-term opioid treatment of chronic pain.","author":"Chou","year":"2014","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"coi220025r18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2018.09.038","article-title":"Mental disorders associated with recent cancer diagnosis: results from a nationally representative survey.","volume":"105","author":"Mallet","year":"2018","journal-title":"European Journal of Cancer"},{"issue":"19","key":"coi220025r19","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1002\/cncr.26082","article-title":"Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients.","volume":"117","author":"Dev","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"coi220025r20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00520-017-3575-1","article-title":"Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.","volume":"25","author":"Rauenzahn","year":"2017","journal-title":"Support Care Cancer"},{"issue":"3","key":"coi220025r21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/cncr.v128.3","article-title":"Approaches to opioid prescribing in cancer survivors: Lessons learned from the general literature.","volume":"128","author":"Jones","year":"2022","journal-title":"Cancer"},{"issue":"2","key":"coi220025r22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11606-017-4211-y","article-title":"Managing concerning behaviors in patients prescribed opioids for chronic pain: a Delphi study.","volume":"33","author":"Merlin","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"4","key":"coi220025r23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder.","volume":"166","author":"Dennis McCarty","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"coi220025r24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13722-016-0050-0","article-title":"Management of patients with issues related to opioid safety, efficacy and\/or misuse: a case series from an integrated, interdisciplinary clinic.","volume":"11","author":"Becker","year":"2016","journal-title":"Addict Sci Clin Pract"},{"issue":"8","key":"coi220025r26","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.techfore.2011.03.021","article-title":"ExpertLens: a system for eliciting opinions from a large pool of non-collocated experts with diverse knowledge.","volume":"78","author":"Dalal","year":"2011","journal-title":"Technol Forecast Soc Change"},{"issue":"1","key":"coi220025r27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1471-2288-11-174","article-title":"Conducting online expert panels: a feasibility and experimental replicability study.","volume":"11","author":"Khodyakov","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"coi220025r28","first-page":"348","article-title":"Developing clinical guidelines.","volume":"170","author":"Shekelle","year":"1999","journal-title":"West J Med"},{"issue":"5","key":"coi220025r29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045402","article-title":"Consensus-based approach to managing opioids, including opioid misuse and opioid use disorder, in patients with serious illness: protocol for a modified Delphi process.","volume":"11","author":"King","year":"2021","journal-title":"BMJ Open"},{"issue":"8","key":"coi220025r30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0272989X19883631","article-title":"Using an online modified-Delphi approach to engage patients and caregivers in determining the patient-centeredness of Duchenne Muscular Dystrophy care considerations.","volume":"39","author":"Khodyakov","year":"2019","journal-title":"Med Decis Making"},{"issue":"2","key":"coi220025r31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/jep.2017.23.issue-2","article-title":"Acceptability of an online modified Delphi panel approach for developing health services performance measures: results from 3 panels on arthritis research.","volume":"23","author":"Khodyakov","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"coi220025r32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/jamia\/ocw157","article-title":"Comparative analysis of stakeholder experiences with an online approach to prioritizing patient-centered research topics.","volume":"24","author":"Khodyakov","year":"2017","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"coi220025r34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/hex.2017.20.issue-1","article-title":"Patient engagement in the process of planning and designing outpatient care improvements at the Veterans Administration Health-care System: findings from an online expert panel.","volume":"20","author":"Khodyakov","year":"2017","journal-title":"Health Expect"},{"issue":"1","key":"coi220025r35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1049909121999783","article-title":"Adapting palliative care skills to provide substance use disorder treatment to patients with serious illness.","volume":"39","author":"Jones","year":"2022","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"coi220025r36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09540261.2017.1288090","article-title":"The burden of psychosocial morbidity related to cancer: patient and family issues.","volume":"29","author":"Caruso","year":"2017","journal-title":"Int Rev Psychiatry"},{"issue":"12","key":"coi220025r37","doi-asserted-by":"publisher","first-page":"e2143436","DOI":"10.1001\/jamanetworkopen.2021.43436","article-title":"A case for palliative care and addiction specialists collaboration and joint research.","volume":"4","author":"Moryl","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"coi220025r38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpainsymman.2020.04.192","article-title":"Managing opioids, including misuse and addiction, in patients with serious illness in ambulatory palliative care: a qualitative study (GP765).","volume":"60","author":"Merlin","year":"2020","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"coi220025r39","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/j.jpainsymman.2021.05.002","article-title":"Compassion inequities and opioid use disorder: a matched case-control analysis examining inpatient management of cancer-related pain for patients with opioid use disorder.","volume":"62","author":"Singh","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"coi220025r40","doi-asserted-by":"publisher","first-page":"931","DOI":"10.7326\/M19-2303","article-title":"Patients with opioid use disorder deserve trained providers.","volume":"171","author":"Weimer","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"coi220025r41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding buprenorphine for use in chronic pain: expert opinion.","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med"},{"issue":"4","key":"coi220025r42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1049909118806664","article-title":"Dying on hospice in the midst of an opioid crisis: what should we do now?","volume":"36","author":"Gabbard","year":"2018","journal-title":"American Journal of Hospice and Palliative Medicine"},{"issue":"6","key":"coi220025r43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/NJH.0000000000000598","article-title":"Buprenorphine use in palliative care.","volume":"21","author":"Jones","year":"2019","journal-title":"J Hosp Palliat Nurs"},{"issue":"6","key":"coi220025r44","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment.","volume":"54","author":"Haffajee","year":"2018","journal-title":"Am J Prev Med"},{"issue":"10","key":"coi220025r45","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/17512433.2020.1822163","article-title":"A narrative review of buprenorphine in adult cancer pain.","volume":"13","author":"Degnan","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"20","key":"coi220025r46","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1200\/JCO.18.01567","article-title":"Comparative efficacy of therapeutics for chronic cancer pain: a Bayesian network meta-analysis.","volume":"37","author":"Huang","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"coi220025r47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids.","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"coi220025r48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2021.11118","article-title":"Opioid tapering practices-time for reconsideration?","volume":"326","author":"Larochelle","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"coi220025r49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review.","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"coi220025r50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5055\/jom.2020.0557","article-title":"Successful use of buprenorphine-naloxone medication-assisted program to treat concurrent pain and opioid addiction after cancer therapy.","volume":"16","author":"Moryl","year":"2020","journal-title":"J Opioid Manag"},{"issue":"9","key":"coi220025r51","doi-asserted-by":"publisher","first-page":"e2124152","DOI":"10.1001\/jamanetworkopen.2021.24152","article-title":"Evaluation of buprenorphine rotation in patients receiving long-term opioids for chronic pain: a systematic review.","volume":"4","author":"Powell","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"coi220025r52","doi-asserted-by":"publisher","first-page":"e1030","DOI":"10.1200\/OP.20.01041","article-title":"This is a different patient population: opioid prescribing challenges for patients with cancer-related pain.","volume":"17","author":"Schenker","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"coi220025r25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-29863-4_6","volume-title":"Methadone and buprenorphine: The place of opiate replacement therapies. Treating comorbid opioid use disorder in chronic pain","author":"Buchholz","year":"2016"},{"key":"coi220025r33","author":"Fitch","year":"2001"},{"key":"coi220025r11","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines Oncology: Adult Cancer version 3.2019. Accessed March 6, 2022. https:\/\/jccn.org\/view\/journals\/jncc\/17\/8\/article-p977.xml"},{"key":"coi220025r12","unstructured":"American Society of Clinicial Oncology. ASCO policy statement on opioid therapy: protecting access to treatment for cancer-related pain. Accessed March 6, 2022. www.asco.org\/sites\/new-www.asco.org\/files\/content-files\/advocacy-and-policy\/documents\/2016-ASCO-Policy-Statement-Opioid-Therapy.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2793858\/jamaoncology_fitzgerald_jones_2022_oi_220025_1660581520.01248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:16:00Z","timestamp":1660821360000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2793858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.2191","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}